EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of a vesicular stomatitis virus pseudotyped with herpes B virus glycoproteins and its application in a neutralizing antibody detection assay

Hitomi Kinoshita, Souichi Yamada, Takuma Ogawa, Phu Hoang Anh Nguyen, Shizuko Harada, Madoka Kawahara, Keita Ishijima, Ken Maeda, Hideki Ebihara, Shuetsu Fukushi iD

mBio · 2024

DOI: 10.1128/mbio.01092-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, 2024. Verfasst von Hitomi Kinoshita und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Virology 1, National Institute of Infectious Diseases, Tokyo, Japan. Hauptthemen laut MEDLINE: Antibodies, Neutralizing, Antibodies, Viral, Virus Internalization. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MEXT | Japan Society for the Promotion of Science (JSPS), Japan Agency for Medical Research and Development (AMED).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Herpes B virus (BV) is a zoonotic virus and belongs to the genus Simplexvius , the same genus as human herpes simplex virus (HSV). BV typically establishes asymptomatic infection in its natural hosts, macaque monkeys. However, in humans, BV infection causes serious neurological diseases and death. As such, BV research can only be conducted in a high containment level facility (i.e., biosafety level [BSL] 4), and the mechanisms of BV entry have not been fully elucidated. In this study, we generated a pseudotyped vesicular stomatitis virus (VSV) expressing BV glycoproteins using G-complemented VSV∆G system, which we named VSV/BVpv. We found that four BV glycoproteins (i.e., gB, gD, gH, and gL) were required for the production of a high-titer VSV/BVpv. Moreover, VSV/BVpv cell entry was dependent on the binding of gD to its cellular receptor nectin-1. Pretreatment of Vero cells with endosomal acidification inhibitors did not affect the VSV/BVpv infection. The result indicated that VSV/BVpv entry occurred by direct fusion with the plasma membrane of Vero cells and suggested that the entry pathway was similar to that of native HSV. Furthermore, we developed a VSV/BVpv-based chemiluminescence reduction neutralization test (CRNT), which detected the neutralization antibodies against BV in macaque plasma samples with high sensitivity and specificity. Crucially, the VSV/BVpv generated in this study can be used under BSL-2 condition to study the initial entry process through gD–nectin-1 interaction and the direct fusion of BV with the plasma membrane of Vero cells. IMPORTANCE Herpes B virus (BV) is a highly pathogenic zoonotic virus against humans. BV belongs to the genus Simplexvius , the same genus as human herpes simplex virus (HSV). By contrast to HSV, cell entry mechanisms of BV are not fully understood. The research procedures to manipulate infectious BV should be conducted in biosafety level (BSL)-4 facilities. As pseudotyped viruses provide a safe viral entry model because of their inability to produce infectious progeny virus, we tried to generate a pseudotyped vesicular stomatitis virus bearing BV glycoproteins (VSV/BVpv) by modification of expression constructs of BV glycoproteins, and successfully obtained VSV/BVpv with a high titer. This study has provided novel information for constructing VSV/BVpv and its usefulness to study BV infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, NeutralizingAntibodies, ViralVirus InternalizationAnimalsChlorocebus aethiopsVero CellsHumansNeutralization TestsVesiculovirusViral Envelope ProteinsGlycoproteinsVesicular stomatitis Indiana virusViral Proteins

Stichwörter der Autor:innen

glycoproteinsherpes B virus (BV)herpes simplex virus (HSV)neutralization assaypseudotypesvesicular stomatitis virus (VSV)

Substanzen

Antibodies, NeutralizingAntibodies, ViralViral Envelope ProteinsGlycoproteinsViral Proteins

Autor:innen und Institutionen

  • Department of Virology 1, National Institute of Infectious Diseases, Tokyo, Japan.
  • Department of Veterinary Science, National Institute of Infectious Diseases, Tokyo, Japan.

ORCID-Profile: Shuetsu Fukushi

Förderung

  • MEXT | Japan Society for the Promotion of Science (JSPS)
  • Japan Agency for Medical Research and Development (AMED)

Zitieren

APA

Kinoshita, H., Yamada, S., Ogawa, T., Nguyen, P. H. A., Harada, S., Kawahara, M., Ishijima, K., Maeda, K., Ebihara, H., & Fukushi, S. (2024). Development of a vesicular stomatitis virus pseudotyped with herpes B virus glycoproteins and its application in a neutralizing antibody detection assay. mBio. https://doi.org/10.1128/mbio.01092-24

Vancouver

Kinoshita H, Yamada S, Ogawa T, Nguyen PHA, Harada S, Kawahara M, et al. Development of a vesicular stomatitis virus pseudotyped with herpes B virus glycoproteins and its application in a neutralizing antibody detection assay. mBio. 2024. doi:10.1128/mbio.01092-24

BibTeX
@article{Kinoshita2024,
  author = {Kinoshita, Hitomi and Yamada, Souichi and Ogawa, Takuma and Nguyen, Phu Hoang Anh and Harada, Shizuko and Kawahara, Madoka and Ishijima, Keita and Maeda, Ken and Ebihara, Hideki and Fukushi, Shuetsu},
  title = {Development of a vesicular stomatitis virus pseudotyped with herpes B virus glycoproteins and its application in a neutralizing antibody detection assay},
  journal = {mBio},
  year = {2024},
  doi = {10.1128/mbio.01092-24}
}
Kostenlos starten →